David P. Meeker, Director, 10% Owner at Trevi Therapeutics, Inc. (TRVI), bought 24,521 shares at $10.00 ($113K) on 2019-05-09, disclosed to the SEC on 2019-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 13,271 | $0 | 0.0% |
| 2 | $10.00 | 11,250 | $113K | 100.0% |
| Total | $4.59 avg | 24,521 | $113K | 100% |
| Filing → |
| RYTM | SELL | 2025-02-19 | $1.1M | — | Filing → |
| RYTM | SELL | 2025-02-04 | $508K | — | Filing → |
| TRVI | SELL | 2024-08-29 | $13K | — | Filing → |